Unclaimed brand
Na Biomm, somos pioneiros em biotecnologia no Brasil, desenvolvendo biomedicamentos inovadores que transformam vidas e impulsionam a ciência.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#33A7B5
Pelorous
51, 167, 181
186, 56, 45
72, 8, 0, 29
#BB8467
Muddy Waters
187, 132, 103
21, 38, 57
0, 29, 45, 27
#2D3E50
Pickled Bluewood
45, 62, 80
211, 28, 25
44, 22, 0, 69
Biomm is a Brazilian biotechnology company focused on developing and commercializing innovative medicines, with the aim of improving health and quality of life for people living with chronic diseases. The company describes itself as a pioneer in biotechnology in Brazil and works to expand access to advanced healthcare technologies while strengthening the country’s productive independence in the pharmaceutical industry.
A key focus is insulin: Biomm has begun national production of insulin glargine, presented as a pioneering achievement in Brazil. Its website also highlights expanded access to glargine through Brazil’s public health system and offers Glargina Pass, a WhatsApp support service with guidance for people transitioning from NPH insulin to glargine. Biomm provides product information and package inserts, alongside a scientific portal for healthcare professionals.
The company also shares information about its factory, biotechnology activities, news, and investor relations. Listed on BM&F-BOVESPA under the ticker BIOM3, Biomm states that it follows governance standards and directs investment inquiries to regulated channels.
